Literature DB >> 19581626

Absence of IFN-beta impairs antigen presentation capacity of splenic dendritic cells via down-regulation of heat shock protein 70.

Natalia Zietara1, Marcin Łyszkiewicz, Nelson Gekara, Jacek Puchałka, Vitor A P Martins Dos Santos, Clayton R Hunt, Tej K Pandita, Stefan Lienenklaus, Siegfried Weiss.   

Abstract

Type I IFNs play a key role in linking the innate and adaptive arms of the immune system. Although produced rapidly in response to pathogens, IFNs are also produced at low levels in the absence of infection. In the present study, we demonstrate that constitutively produced IFNs are necessary in vivo to maintain dendritic cells in an "Ag presentation-competent" state. Conventional dendritic cells (cDCs) isolated from spleens of IFN-beta or IFNAR-deficient mice exhibit a highly impaired ability to present Ag and activate naive T cells. Microarray analysis of mRNA isolated from IFN-beta(-/-) and IFNAR(-/-) cDCs revealed diminished expression of two genes that encoded members of the heat shock protein 70 (Hsp70) family. Consistent with this observation, pharmacological inhibition of Hsp70 in cDCs from wild-type mice impaired their T cell stimulatory capacity. Similarly, the Ag presentation ability of splenic cDCs isolated from Hsp70.1/3(-/-) mice was also severely impaired in comparison to wild-type cDCs. Thus, constitutive IFN-beta expression regulates Hsp70 levels to help maintain dendritic cells in a competent state for efficient priming of effector T cells in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581626      PMCID: PMC2756009          DOI: 10.4049/jimmunol.0803214

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  Roles of heat-shock proteins in antigen presentation and cross-presentation.

Authors:  Zihai Li; Antoine Menoret; Pramod Srivastava
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

Review 2.  A weak signal for strong responses: interferon-alpha/beta revisited.

Authors:  T Taniguchi; A Takaoka
Journal:  Nat Rev Mol Cell Biol       Date:  2001-05       Impact factor: 94.444

3.  IFN-alpha beta promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines.

Authors:  Hearn Jay Cho; Tomoko Hayashi; Sandip K Datta; Kenji Takabayashi; John Henry Van Uden; Anthony Horner; Maripat Corr; Eyal Raz
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

Review 4.  Links between innate and adaptive immunity via type I interferon.

Authors:  Agnes Le Bon; David F Tough
Journal:  Curr Opin Immunol       Date:  2002-08       Impact factor: 7.486

Review 5.  Origin, precursors and differentiation of mouse dendritic cells.

Authors:  Carlos Ardavín
Journal:  Nat Rev Immunol       Date:  2003-07       Impact factor: 53.106

6.  Most lymphoid organ dendritic cell types are phenotypically and functionally immature.

Authors:  Nicholas S Wilson; Dima El-Sukkari; Gabrielle T Belz; Christopher M Smith; Raymond J Steptoe; William R Heath; Ken Shortman; José A Villadangos
Journal:  Blood       Date:  2003-06-05       Impact factor: 22.113

7.  In vivo administration of 15-deoxyspergulin inhibits antigen-presenting cell stimulation of T cells and NF-kappaB activation.

Authors:  Michael L Diegel; Steven G Nadler; Peter A Kiener
Journal:  Int Immunopharmacol       Date:  2002-09       Impact factor: 4.932

Review 8.  Mouse and human dendritic cell subtypes.

Authors:  Ken Shortman; Yong-Jun Liu
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

9.  The role of heat shock protein (hsp70) in dendritic cell maturation: hsp70 induces the maturation of immature dendritic cells but reduces DC differentiation from monocyte precursors.

Authors:  M C Kuppner; R Gastpar; S Gelwer; E Nössner; O Ochmann; A Scharner; R D Issels
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

10.  Heat shock protein 70 moderately enhances peptide binding and transport by the transporter associated with antigen processing.

Authors:  D Chen; M J Androlewicz
Journal:  Immunol Lett       Date:  2001-01-01       Impact factor: 3.685

View more
  19 in total

1.  Beta interferon controls West Nile virus infection and pathogenesis in mice.

Authors:  Helen M Lazear; Amelia K Pinto; Matthew R Vogt; Michael Gale; Michael S Diamond
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

2.  High affinity binding of hydrophobic and autoantigenic regions of proinsulin to the 70 kDa chaperone DnaK.

Authors:  Volker Burkart; Rahel K Siegenthaler; Elias Blasius; Koen Vandenbroeck; Iraide Alloza; Waltraud Fingberg; Nanette C Schloot; Philipp Christen; Hubert Kolb
Journal:  BMC Biochem       Date:  2010-11-08       Impact factor: 4.059

3.  The effects of chemotherapeutic drugs on human monocyte-derived dendritic cell differentiation and antigen presentation.

Authors:  J Hu; J Kinn; A A Zirakzadeh; A Sherif; G Norstedt; A-C Wikström; O Winqvist
Journal:  Clin Exp Immunol       Date:  2013-06       Impact factor: 4.330

4.  Polyinosinic-polycytidylic acid has therapeutic effects against cerebral ischemia/reperfusion injury through the downregulation of TLR4 signaling via TLR3.

Authors:  Peng-Fei Wang; Huang Fang; Jing Chen; Sen Lin; Yong Liu; Xiao-Yi Xiong; Yan-Chun Wang; Ren-Ping Xiong; Feng-Lin Lv; Jian Wang; Qing-Wu Yang
Journal:  J Immunol       Date:  2014-04-11       Impact factor: 5.422

5.  IFNAR signaling directly modulates T lymphocyte activity, resulting in milder experimental autoimmune encephalomyelitis development.

Authors:  Nadia Kavrochorianou; Maria Evangelidou; Melina Markogiannaki; Michael Tovey; George Thyphronitis; Sylva Haralambous
Journal:  J Leukoc Biol       Date:  2015-07-31       Impact factor: 4.962

6.  Discovery of Intermediary Genes between Pathways Using Sparse Regression.

Authors:  Kuo-ching Liang; Ashwini Patil; Kenta Nakai
Journal:  PLoS One       Date:  2015-09-08       Impact factor: 3.240

7.  Tumor-derived inducible heat-shock protein 70 (HSP70) is an essential component of anti-tumor immunity.

Authors:  K Dodd; S Nance; M Quezada; L Janke; J B Morrison; R T Williams; H M Beere
Journal:  Oncogene       Date:  2014-03-24       Impact factor: 9.867

8.  Temporal analysis of type 1 interferon activation in tumor cells following external beam radiotherapy or targeted radionuclide therapy.

Authors:  Justin C Jagodinsky; Won Jong Jin; Amber M Bates; Reinier Hernandez; Joseph J Grudzinski; Ian R Marsh; Ishan Chakravarty; Ian S Arthur; Luke M Zangl; Ryan J Brown; Erin J Nystuen; Sarah E Emma; Caroline Kerr; Peter M Carlson; Raghava N Sriramaneni; Jonathan W Engle; Eduardo Aluicio-Sarduy; Todd E Barnhart; Trang Le; KyungMann Kim; Bryan P Bednarz; Jamey P Weichert; Ravi B Patel; Zachary S Morris
Journal:  Theranostics       Date:  2021-04-15       Impact factor: 11.600

9.  Hsp70 and its molecular role in nervous system diseases.

Authors:  Giuseppina Turturici; Gabriella Sconzo; Fabiana Geraci
Journal:  Biochem Res Int       Date:  2011-02-24

10.  Type I interferon is selectively required by dendritic cells for immune rejection of tumors.

Authors:  Mark S Diamond; Michelle Kinder; Hirokazu Matsushita; Mona Mashayekhi; Gavin P Dunn; Jessica M Archambault; Hsiaoju Lee; Cora D Arthur; J Michael White; Ulrich Kalinke; Kenneth M Murphy; Robert D Schreiber
Journal:  J Exp Med       Date:  2011-09-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.